SCHEMBL6932233

SCHEMBL6932233

NCC(=O)Nc1ccc(NC(=O)C(F)(F)F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.57
CA2 P00918 3/20 0.57
CA12 O43570 1/20 0.57
CA9 Q16790 1/20 0.57
MAPT P10636 1/20 0.50
TERT O14746 1/20 0.49
TAAR1 Q96RJ0 1/20 0.47
LTA4H P09960 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
RAB9A P51151 1/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18227059 0.81 CA12 (0.57) CA1CA2CA12CA9MAPT
SCHEMBL13356394 0.81 EPHX2 (0.63) CA1CA2CA12CA9MAPT
Trifluoroacetic Acid SCHEMBL6932239 0.81 CA1 (0.50) CA1CA2MAPTTERTTAAR1
SCHEMBL24246205 0.80 CA1 (0.49) CA1CA2CA12CA9MAPT
Trifluoroacetic Acid SCHEMBL29406683 0.80 ALDH1A1 (0.51) CA1CA2MAPTLTA4HMEN1
SCHEMBL5718053 0.79 GAA (0.63) CA1CA2CA12CA9TERT
SCHEMBL3454327 0.79 CA12 (0.62) CA1CA2CA12CA9MAPT
SCHEMBL20941547 0.78 HDAC1 (0.61) CA1CA2CA12CA9MAPT
Trifluoroacetic Acid SCHEMBL6932230 0.78 MLYCD (0.48) CA1CA2MAPTLTA4HMEN1
SCHEMBL11077344 0.77 CA12 (0.56) CA1CA2CA12CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0859000-B1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof AVENTIS PHARMA GMBH (DE) 2003-01-22 EP claimed
US-5977151-A ANTITUMOR HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 US claimed
US-6265588-B1 USE AS PHARMACEUTICALS; AS AN ANTIGEN FOR PRODUCTION OF ANTIBODIES AND IN DIAGNOSIS AND PURIFICATION AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-07-24 US disclosed
US-6121479-A ANTIINFLAMMATORY AND ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 2000-09-19 US disclosed
US-5977151-A ANTITUMOR HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 US disclosed